Iraq vs Micronesia (country): Statin use vs. average non-HDL cholesterol levels
Iraq
3.5
in 2018
Micronesia (country)
3.5
in 2018
Iraq rank
52nd
Micronesia (country) rank
52nd
Statin use vs. average non-HDL cholesterol levels over time
- Iraq
- Micronesia (country)
How they compare
Iraq currently reports 3.5 against 3.5 in Micronesia (country), a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Iraq ahead.
Iraq ranks 52nd and Micronesia (country) ranks 52nd of 191 countries.
Iraq has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Iraq | Micronesia (country) | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.75 | 3.52 | 0.23 | Iraq |
| 1990s | 3.8 | 3.68 | 0.12 | Iraq |
| 2000s | 3.75 | 3.56 | 0.19 | Iraq |
| 2010s | 3.58 | 3.5 | 0.0778 | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Iraq or Micronesia (country)?
- Iraq, at 3.5 against 3.5 in Micronesia (country) as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Iraq and Micronesia (country)?
- 0, with Iraq ahead.
- How many years of comparable data are there for Iraq and Micronesia (country)?
- 39 years are reported by both, from 1980 to 2018.
- How do Iraq and Micronesia (country) rank globally for statin use vs. average non-hdl cholesterol levels?
- Iraq ranks 52nd and Micronesia (country) ranks 52nd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.